Synopsys, Inc. $SNPS Shares Bought by Swiss Life Asset Management Ltd

Swiss Life Asset Management Ltd raised its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 18.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 70,738 shares of the semiconductor company’s stock after buying an additional 11,111 shares during the period. Swiss Life Asset Management Ltd’s holdings in Synopsys were worth $34,901,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Alpine Bank Wealth Management boosted its holdings in Synopsys by 89.3% during the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock valued at $26,000 after acquiring an additional 25 shares during the period. TFC Financial Management Inc. increased its stake in Synopsys by 1,250.0% during the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock worth $27,000 after purchasing an additional 50 shares during the period. Millstone Evans Group LLC purchased a new stake in Synopsys during the third quarter worth about $27,000. SOA Wealth Advisors LLC. acquired a new stake in shares of Synopsys during the third quarter worth about $28,000. Finally, McIlrath & Eck LLC acquired a new stake in shares of Synopsys during the third quarter worth about $29,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently weighed in on SNPS. Citigroup initiated coverage on shares of Synopsys in a report on Monday, November 24th. They issued a “buy” rating and a $580.00 price objective for the company. Rosenblatt Securities reduced their target price on shares of Synopsys from $560.00 to $530.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Bank of America upgraded shares of Synopsys from an “underperform” rating to a “neutral” rating and dropped their price target for the stock from $525.00 to $500.00 in a research note on Monday, December 8th. KeyCorp upped their price objective on Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a research report on Thursday, December 11th. Finally, Needham & Company LLC reiterated a “buy” rating on shares of Synopsys in a research note on Thursday, February 26th. Eight investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $531.00.

Insider Buying and Selling at Synopsys

In related news, insider Janet Lee sold 250 shares of the stock in a transaction on Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the transaction, the insider owned 11,959 shares of the company’s stock, valued at $6,338,270. This represents a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the sale, the chief financial officer owned 17,842 shares in the company, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 4,157 shares of company stock worth $1,945,036 in the last three months. 0.56% of the stock is currently owned by corporate insiders.

Synopsys Stock Down 0.1%

Shares of NASDAQ:SNPS opened at $428.67 on Thursday. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The firm’s 50 day moving average price is $457.15 and its 200 day moving average price is $459.91. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33. The stock has a market cap of $82.12 billion, a price-to-earnings ratio of 66.56, a price-to-earnings-growth ratio of 3.50 and a beta of 1.15.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, topping the consensus estimate of $3.56 by $0.21. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The company had revenue of $2.41 billion during the quarter, compared to analysts’ expectations of $2.39 billion. During the same quarter in the previous year, the business posted $3.03 EPS. The firm’s revenue was up 65.6% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. As a group, equities research analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.